D-Ribose-1,2-13C2

• UNSPSC Description:

  D-Ribose-1,2-13C2 is the 13C labled D-Ribose(mixture of isomers) (HY-W018772)[1]. D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[2].

• Target Antigen:

  Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/d-ribose-1-2-13c2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC[C@@H](O)[C@@H](O)[13C@@H](O)[13CH]=O

• Molecular Weight:

  152.12

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  209909-88-6